Real support for people living with multiple sclerosis

  • 73,263 members living with multiple sclerosis
  • 26 new members this month

You know how you feel. So do they.
Join PatientsLikeMe to compare treatments, track symptoms, and get advice and support from the ones who understand multiple sclerosis most: those living with it.

Access real-world data

"It’s fantastic, this database of information. I just can’t tell you how valuable this is. It’s more important to me than any other resource that I have. So much information. It’s great."

member 6.02x10e23

Learn about treatments

"PatientsLikeMe has been an amazing resource for me. It allows me to see how other people are affected by any number of treatments. Furthermore, it allows me to share my own treatment stories to help others."

member chilli123

Share your experience

"MS is not a disease that can be tackled alone. PatientsLikeMe is a place you can curl up into the comfort of others who know what you are going though. They understand."

member sirsmedley

Track your symptoms

Track your health over time and see symptoms from others with RRMS, SPMS, PPMS, and PRMS

Commonly tracked symptoms
  • fatigue

  • stiffness/spasticity

  • balance problems

  • back pain

Start tracking now

Compare multiple sclerosis treatments

See which treatments others are using to treat their symptoms

Commonly tracked treatments
  • Ocrelizumab
    (Ocrevus)
  • Ofatumumab
    (Kesimpta)
  • Dimethyl fumarate
    (Tecfidera)
  • Vumerity

Compare more treatments now

What makes PatientsLikeMe different?

Photo of Jamie, Ben and Steven Heywood

Founded by Family

"Our brother Stephen was living with ALS and we thought, ‘there has to be a better way.’ There is."

Jamie & Ben Heywood, Co-founders

Focused on Members

Living with a serious illness can sometimes feel like you’re alone. You are not alone. Meet John and hear why he's more than MS.

data for good

Devoted to Data

Tracking the symptoms of multiple sclerosis helps our community manage their health today and helps researchers shorten the path to new treatments tomorrow.